Fever and infectious complications in patient with lung cancer;Fièvre et complications infectieuses chez un patient porteur d'un cancer bronchique

Revue de Pneumologie Clinique

Volumn 64, Issue 2, 2008, Pages 99-103

  Merad Taoufik, M ^a   Antoun, S ^a   Ruffie P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Antibiotic; Fever; Infection; Lung cancer; Neutropenia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTINEOPLASTIC AGENT; ERLOTINIB; GATIFLOXACIN; GEFITINIB; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLUENZA VACCINE; MOXIFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TAXANE DERIVATIVE;

AGE; CANCER MORTALITY; CANCER SURVIVAL; CANDIDA; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEVER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; INFLUENZA; KLEBSIELLA PNEUMONIAE; LUNG CANCER; LUNG RESECTION; MORAXELLA CATARRHALIS; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PATHOGENESIS; PATIENT EDUCATION; PNEUMOCOCCAL INFECTION; PSEUDOMONAS; RESPIRATORY TRACT INFECTION; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; CARCINOMA, BRONCHOGENIC; FEVER OF UNKNOWN ORIGIN; HUMANS; LUNG NEOPLASMS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PALLIATIVE CARE; PNEUMONIA, BACTERIAL; SURVIVAL RATE;

EID: 68649111399     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneumo.2008.04.008     Document Type: Review

References (34)

1. Zell J.A., and Chang J.C. Neoplastic fever: a neglected paraneoplastic syndrome. Support Care Cancer 13 (2005) 870-877
2. Kern W.V., Cometta A., De Bock R., Langenaeken J., Paesman M., Gaya H., and International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 341 (1999) 312-318
3. Gaytan-Martinez J., Mateos-Garcia E., Sanchez-Cortez E., Gonzales-Llaven J., Casanova-Cardiel L.J., and Fuentes-Allen J.L. Microbiological findings in febrile neutropenia. Arch Med Res 31 (2000) 388-392
4. Vento S., and Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol 4 (2003) 595-604
5. Toussaint E., Bahell-Ball E., Vekemans L., Georgala A., Al-Hakak L., Paesmans M., et al. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 14 (2006) 763-769
6. Nagata N., Nikaido Y., Kido M., Ishibashi T., and Sueishi K. Terminal pulmonary infections in patients with lung cancer. Chest 103 (1993) 1739-1742
7. Van Houtte P., Gregor A., and Philips P. International survey of radiotherapy practice for radical treatment of non-small cell lung cancer. Lung Cancer 11 Suppl. 3 (1994) S129-S138
8. Bodey G.P., Buckley M., Sathe Y.S., and Freireich E.J. Quantitative relatioships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64 (1966) 328-340
9. Seo S.K. Infectious complications of lung cancer. Oncology 19 (2005) 185-194
10. Banerji U., Ashley S., Coward J., Hugues S., Zee Y., Benepal T., et al. The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer. Lung Cancer 54 (2006) 371-377
11. Markman M., and Abeloff M.D. Management of hematologic and infectious complications of intensive induction therapy of small cell carcinoma of the lung. Am J Med 74 (1983) 741-746
12. Pluquet E., and Gouzi F. Antibiothérapie dans la neutropénie fébrile post-chimiothérapie dans le cancer pulmonaire : étude épidémiologique descriptive multicentrique. Rev Mal Respir 24 (2007) 1S7-1S30
13. Berghmans T., Sculier J.P., and Klastersky J. A prospective study of infections in lung cancer patients admitted to the hospital. Chest 124 (2003) 114-120
14. Fuks J.Z., Patel H., Hornedo J., Van Echo D.A., Moody M., and Aisner J. Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapy. Med Pediatr Oncol 14 (1986) 255-261
15. Brambilla C., Roman P., Vanderkerckhove C., and Moro D. Infection respiratoire et cancer bronchique. Rev Mal Respir 9 Suppl. 1 (1999) R49-R52
16. Perlin E., Bang K.M., Shah A., Hursey P.D., Whittingham W.L., Hashmi K., et al. The impact of pulmonary infections on the survival of lung cancer patients. Cancer 66 (1990) 593-596
17. Jiang Y., Li J.Y., Li M., Zhou L., Peng F., and Wei W.Q. Clinical analysis of nosocomial pulmonary fungal infection in patients with cancer. Ai Zheng 23 (2004) 1707-1709
18. Pizzo P.A. Fever in immunocompromised patients. N Engl J Med 341 (1999) 893-900
19. Hugues W.T., Amstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
20. Blum U., Windfuhr M., Buitrago-Tellez C., Sigmund G., Herbst E.W., and Langer M. Invasive pulmonary aspergillosis MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 106 (1994) 1156-1161
21. Ortbals D.W., and Marr J.J. A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis 117 (1978) 39-45
22. Mera J.R., Whimbey E., Elting L., Pretti A., Luna M.A., Bruner J.M., et al. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: review of 20 cases occuring from 1964 through 1990. Clin Infect Dis 22 (1996) 1046-1050
23. Mayaud C., Cabasso J., Fartoukh M., and Parrot A. Insuffisance respiratoire aiguë chez le patient atteint d'un cancer broncho-pulmonaire. Reanimation 5 (1998) 129-144
24. Dournon E., and de Truchis P. Maladies des légionnaires. Immunité et Immunodépression. Nouv Rev Fr Hematol 24 (1982) 321-333
25. Dournon E. La maladie des légionnaires chez l'immunodéprimé. Facteurs de risque et pronostic. In: Pneumopathies aiguës sévères de l'adulte. Pocido JJ, Vachon F. Arnette: Paris; 1983. p. 229-41.
26. Nunnink J.C., Gallagher J.G., and Yates J.W. Legionnaires' disease in patients with cancer. Pediatr Oncol 14 (1986) 81-85
27. Bandak S.I., Turnak M.R., Allen B.S., Bolzon L.D., Preston D.A., Bouchillon S.K., et al. Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries. Eur J Clin Microbiol Infect Dis 20 (2001) 55-60
28. Lipsky B.A., Boyko E.J., Inui T.S., and Koepsell T.D. Risk factors for acquiring pneumococcal infections. Arch Intern Med 146 (1986) 2179-2185
29. Putinati S., Trevisani L., Gualandi M., Guerra G., Rossi M.R., Sartori S., et al. Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer 11 (1994) 243-249
30. Remiszewski P., Slodkowska J., Wiatr E., Zych J., Radomski P., and Rowinska-Zakrzewska E. Fatal infection in patients treated for small cell lung cancer in the institute of tuberculosis and chest diseases in the years 1980-1994. Lung Cancer 31 (2001) 101-110
31. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346 (2002) 92-98
32. Aapro M.S., Cameron D.A., Pettengell R., Bohlius J., Crawford J., Ellis M., et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42 (2006) 2433-2453
33. Smith T.J., Khatcheressian J., Lyman G.H., Ozer H., Armitage J.O., Balducci L., et al. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24 (2006) 3187-3205
34. Grossi F., and Tiseo M. Granulocyte growth factors in the treatment of non-small cell lung cancer. Crit Rev Oncol Hematol 58 (2006) 221-230